Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Morphine Stories

Opioid Prescriptions Nearly Double
2013-09-16 11:11:23

Michael Harper for redOrbit.com - Your Universe Online More research has been released this week which examines the extent of America’s growing addiction to opioid painkillers. In the last three weeks two studies have been published highlighting this disturbing trend and warning of the dangers therein. A study published last week found that the number of opioid prescriptions for non-cancer pain has almost doubled in the past decade. What’s more, prescriptions for non-opioid...

Pain Sensitivity Heightened By Continued Use Of Codeine
2013-09-13 04:44:22

April Flowers for redOrbit.com - Your Universe Online Researchers at the University of Adelaide's Discipline of Pharmacology have found that a heightened sensitivity to pain might result from using large and frequent doses of the pain-killer codeine, without the same relief offered by morphine. The findings, published in Neurology Reviews, are the result of what is believed to be the world's first experimental study comparing the pain relieving and pain worsening effects of both codeine...

Opioid Painkillers To Get New Addiction-Warning Labels
2013-09-11 11:01:32

Michael Harper for redOrbit.com - Your Universe Online The FDA announced plans to change the way opioid painkillers will be labeled in an effort to sheer off climbing addiction numbers. The new labels will emphasize the potential dangers of the drugs, particularly extended-release and long-acting varieties, while emphasizing that safer options should be considered before prescribing these drugs. Going beyond the labels, the FDA will also begin requiring drug manufacturers to do their...

2013-09-10 08:29:08

These positive results provide Relmada Therapeutics the bases for filing the request with the FDA in the fourth quarter of this year to discuss the Phase III of development for LevoCap ER and the potential pathway for the NDA. NEW YORK, Sept. 10, 2013 /PRNewswire/ -- Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the...

2013-09-05 12:28:29

PALO ALTO, Calif., Sept. 5, 2013 /PRNewswire/ -- Signature Therapeutics, Inc., today presented four scientific posters at the PAINWeek 2013 national conference in Las Vegas. The posters illustrate the company's (i) trypsin-labile, immediate- and extended-release opioid prodrugs that release the parent opioid following oral administration; (ii) results of extended-release prodrugs oxycodone and hydromorphone withstanding tampering and abuse using standard crushing and extracting...

2013-08-29 16:25:25

MAPLE GROVE, Minn., Aug. 29, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced its Morphine Sulfate Extended-Release Capsules, CII will be commercially available on September 4, 2013. (Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO ) Historically, there have been a limited number of morphine sulfate generics available. Upsher-Smith used its extensive formulation experience to overcome the challenges presented. Upsher-Smith's family of Morphine...

2013-08-27 23:29:33

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain. Birmingham, Alabama (PRWEB) August 27, 2013 *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact us directly at (205) 380-6434. There is no cost...

2013-08-27 20:22:44

Additional time required to prepare and review respiratory data from Study 022 SYDNEY and BEDMINSTER, N.J., Aug. 27, 2013 /PRNewswire-USNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Company's MOXDUO New Drug Application (NDA) for the treatment of moderate to severe acute pain. The Company confirmed the issuance of the CRL was to allow time to...

2013-08-23 23:02:49

Linkage Between Heroin and Prescription Medications Reveals Opiate Addiction Epidemic: Failures of Traditional Rehab Los Angeles, CA (PRWEB) August 23, 2013 Based on findings from the U.S. Substance Abuse and Mental Health Services Administration, as revealed by US News & World Report, Americans aged 12 to 49 who had used prescription pain relievers illegally were 19 times more likely to have started using heroin within the past year than other people. This study is no surprise to...

2013-08-21 23:24:11

There has been an overwhelming increase in heroin use in the United States as users seek the drug because it's cheap and readily available compared to prescriptions. Heroin abusers can seek the help they need at a detox center such as Harbor Village to start the recovery process. Miami, Florida (PRWEB) August 21, 2013 According to Fox News (8/1) in their news story titled, Dr. Manny: Heroin on the rise: cheap, available and out of control, that heroin use is rising rapidly in the...